Presenter: Carol Mayfield, CRNP  AHN Osteoporosis and Fragility Fracture Clinic

Objectives:

1. Define osteoporosis
2. Discuss methods of diagnosing osteoporosis
3. Discuss the concept of guideline-directed therapy
4. Apply risk stratification to guide initial drug selection
5. Classify osteoporosis medications by mechanisms of action
6. Compare the fracture risk reduction of available agents
7. Identify key adverse effects and contraindications for each drug class
8. Describe the rational for treatment sequencing
9. Outline treatment duration and drug holiday strategies
10. Discuss non-pharmacologic measures with drug therapy

This CME event qualifies for 0.75 hours of pharmacology credit.